Nephron Pharmaceuticals raises $350m to support future growth
The US-based firm will use the investment to fund its future growth in the production of manufactures safe,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Sep 23
The US-based firm will use the investment to fund its future growth in the production of manufactures safe,…
19 Sep 23
The approval was based on the findings from the MOMENTUM study and a subpopulation of anaemia patients from…
19 Sep 23
CRYOcheck Factor VIII Deficient Plasma with VWF is intended for use in clinical laboratories to identify factor VIII…
15 Sep 23
Following the CHMP's positive opinion, the European Commission will decide whether to approve the modified Covid-19 vaccine from…
14 Sep 23
Under the partnership, Laboratorio Curie will use the SOPHiA DDM Platform technology to deploy a new test for…
14 Sep 23
The decision to discontinue the trial was based on the recommendation of the Data Safety Monitoring Board (DSMB)…
14 Sep 23
Investment will support rapid growth of Sempre's life sciences and payer networks and expansion into adjacent product areas
13 Sep 23
SEQUENCE, a Phase 3 head-to-head study (study drug open-label and efficacy assessment blinded) compared risankizumab to ustekinumab for…
12 Sep 23
The FDA approval was supported by findings from the two-part, Phase 3 GENESIS trial in which the combination…
12 Sep 23
Vibegron Met Both Co-Primary Endpoints Demonstrating Statistically Significant Reductions in Daily Micturition and Urgency Episodes, Compared to Placebo…